These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38823725)

  • 1. The molecular mechanism of ferroptosis and its relationship with Parkinson's disease.
    Su Y; Jiao Y; Cai S; Xu Y; Wang Q; Chen X
    Brain Res Bull; 2024 Jul; 213():110991. PubMed ID: 38823725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis.
    Jiang X; Wu K; Ye XY; Xie T; Zhang P; Blass BE; Bai R
    Med Res Rev; 2023 Jul; 43(4):872-896. PubMed ID: 36924451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential.
    Ding XS; Gao L; Han Z; Eleuteri S; Shi W; Shen Y; Song ZY; Su M; Yang Q; Qu Y; Simon DK; Wang XL; Wang B
    Ageing Res Rev; 2023 Nov; 91():102077. PubMed ID: 37742785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
    Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
    Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis: A potential therapeutic target for neurodegenerative diseases.
    Vitalakumar D; Sharma A; Flora SJS
    J Biochem Mol Toxicol; 2021 Aug; 35(8):e22830. PubMed ID: 34047408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
    Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
    Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Insights on Ferroptosis in Parkinson's disease.
    Thapa K; Khan H; Kanojia N; Singh TG; Kaur A; Kaur G
    Eur J Pharmacol; 2022 Sep; 930():175133. PubMed ID: 35792170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis and Its Role in Diverse Brain Diseases.
    Weiland A; Wang Y; Wu W; Lan X; Han X; Li Q; Wang J
    Mol Neurobiol; 2019 Jul; 56(7):4880-4893. PubMed ID: 30406908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease.
    Thirupathi A; Marqueze LF; Outeiro TF; Radak Z; Pinho RA
    Neurochem Res; 2024 Jul; 49(7):1643-1654. PubMed ID: 38782838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.
    Do Van B; Gouel F; Jonneaux A; Timmerman K; Gelé P; Pétrault M; Bastide M; Laloux C; Moreau C; Bordet R; Devos D; Devedjian JC
    Neurobiol Dis; 2016 Oct; 94():169-78. PubMed ID: 27189756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Zheng Q; Ma P; Yang P; Zhai S; He M; Zhang X; Tu Q; Jiao L; Ye L; Feng Z; Zhang C
    Neurosci Lett; 2023 Jul; 810():137346. PubMed ID: 37308056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases.
    Lei J; Chen Z; Song S; Sheng C; Song S; Zhu J
    Front Cell Neurosci; 2020; 14():231. PubMed ID: 32848622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis.
    Li M; Zhang J; Jiang L; Wang W; Feng X; Liu M; Yang D
    BMC Complement Med Ther; 2023 Jul; 23(1):218. PubMed ID: 37393274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Death-Osis of Dopaminergic Neurons and the Role of Iron in Parkinson's Disease.
    Lima IS; Pêgo AC; Barros JT; Prada AR; Gozzelino R
    Antioxid Redox Signal; 2021 Aug; 35(6):453-473. PubMed ID: 33233941
    [No Abstract]   [Full Text] [Related]  

  • 16. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
    Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorting Nexin 5 Plays an Important Role in Promoting Ferroptosis in Parkinson's Disease.
    Huang Z; Han J; Wu P; Wu C; Fan Y; Zhao L; Hao X; Chen D; Zhu M
    Oxid Med Cell Longev; 2022; 2022():5463134. PubMed ID: 35571244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse and neurodegenerative diseases: focus on ferroptosis.
    Guo C; Chen L; Wang Y
    Arch Toxicol; 2023 Jun; 97(6):1519-1528. PubMed ID: 37100932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease.
    Lin KJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.
    Lu L; Jifu C; Xia J; Wang J
    Biomed Pharmacother; 2024 Jun; 175():116753. PubMed ID: 38761423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.